Semaglutide

Semaglutide is a GLP-1 receptor agonist that mimics the GLP-1 hormone, boosting insulin release and helping lower blood sugar levels. Read more about Semaglutide, Key Findings, Uses, Latest News

Semaglutide
Table of Contents

Semaglutide Latest News

Hyderabad-based Natco Pharma recently received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic semaglutide injection in India.

About Semaglutide

  • It belongs to a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. 
  • It mimics the GLP-1 hormone, released in the gut in response to eating.
  • One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose).
  • For that reason, semaglutide is used for the following:
    • to control blood sugar levels in certain patients with type 2 diabetes (a condition in which blood sugar is too high because the body does not make or use insulin normally).
    • to reduce the risk of a heart attack, stroke, or death in adults with type 2 diabetes and heart and blood vessel disease.
    • to reduce the risk of a heart attack, stroke, or death in adults who are obese or overweight and have heart and blood vessel disease.
    • to reduce the risk of worsening of kidney disease and death in certain adults with type 2 diabetes and kidney disease
    • to assist with weight loss in certain people who are obese or overweight and have weight-related medical problems.

Source: CN

Update Icon
Latest UPSC Exam 2026 Updates

Date IconLast updated on March, 2026

UPSC Final Result 2025 is now out.

→ UPSC has released UPSC Toppers List 2025 with the Civil Services final result on its official website.

Anuj Agnihotri secured AIR 1 in the UPSC Civil Services Examination 2025.

UPSC Marksheet 2025 is now out.

UPSC Notification 2026 & UPSC IFoS Notification 2026 is now out on the official website at upsconline.nic.in.

UPSC Calendar 2026 has been released.

→ Check out the latest UPSC Syllabus 2026 here.

UPSC Prelims 2026 will be conducted on 24th May, 2026 & UPSC Mains 2026 will be conducted on 21st August 2026.

→ The UPSC Selection Process is of 3 stages-Prelims, Mains and Interview.

→ Prepare effectively with Vajiram & Ravi’s UPSC Prelims Test Series 2026 featuring full-length mock tests, detailed solutions, and performance analysis.

→ Enroll in Vajiram & Ravi’s UPSC Mains Test Series 2026 for structured answer writing practice, expert evaluation, and exam-oriented feedback.

→ Join Vajiram & Ravi’s Best UPSC Mentorship Program for personalized guidance, strategy planning, and one-to-one support from experienced mentors.

Shakti Dubey secures AIR 1 in UPSC CSE Exam 2024.

→ Also check Best UPSC Coaching in India

Semaglutide FAQs

Q1. What class of medications does semaglutide belong to?+

Q2. What hormone does semaglutide mimic in the body?+

Q3. When is the GLP-1 hormone released in the body?+

Q4. How does semaglutide help reduce blood sugar levels?+

Tags: prelims pointers semaglutide upsc current affairs upsc prelims current affairs

Vajiram Content Team
Vajiram Content Team
UPSC GS Course 2026
UPSC GS Course 2026
₹1,75,000
Enroll Now
GS Foundation Course 2 Yrs
GS Foundation Course 2 Yrs
₹2,45,000
Enroll Now
UPSC Mentorship Program
UPSC Mentorship Program
₹85000
Enroll Now
UPSC Sureshot Mains Test Series
UPSC Sureshot Mains Test Series
₹19000
Enroll Now
Prelims Powerup Test Series
Prelims Powerup Test Series
₹8500
Enroll Now
Enquire Now